| Q37423988 | A genomic case study of desmoplastic small round cell tumor: comprehensive analysis reveals insights into potential therapeutic targets and development of a monitoring tool for a rare and aggressive disease. |
| Q38347709 | A tetraspanin-family protein, T-cell acute lymphoblastic leukemia-associated antigen 1, is induced by the Ewing's sarcoma-Wilms' tumor 1 fusion protein of desmoplastic small round-cell tumor |
| Q33654843 | Antiangiogenic effects in patients with progressive desmoplastic small round cell tumor: data from the French national registry dedicated to the use of off-labeled targeted therapy in sarcoma (OUTC's) |
| Q33408460 | Characterization of inhibitory anti-insulin-like growth factor receptor antibodies with different epitope specificity and ligand-blocking properties: implications for mechanism of action in vivo |
| Q33259363 | Coexpression of an unusual form of the EWS-WT1 fusion transcript and interleukin 2/15 receptor betamRNA in a desmoplastic small round cell tumour |
| Q39025917 | Desmoplastic small round cell tumor 20 years after its discovery |
| Q44576314 | Desmoplastic small round cell tumor presenting as a neck mass: a case report |
| Q33304145 | Desmoplastic small round cell tumor: a clinicopathologic, immunohistochemical and molecular study of four patients |
| Q34250202 | Desmoplastic small round cell tumour: characteristics and prognostic factors of 41 patients and review of the literature |
| Q74462743 | Detection of EWS-WT1 fusion mRNA in ascites of a patient with desmoplastic small round cell tumor by RT-PCR |
| Q37512587 | Development of IGF-IR Inhibitors in Pediatric Sarcomas. |
| Q52531695 | Dysregulation of the type 1 IGF receptor as a paradigm in tumor progression. |
| Q37993924 | Ewing sarcoma/peripheral primitive neuroectodermal tumor and related tumors. |
| Q35587544 | Expression of connective tissue growth factor (CCN2) in desmoplastic small round cell tumour |
| Q38972581 | GSK3 protein positively regulates type I insulin-like growth factor receptor through forkhead transcription factors FOXO1/3/4 |
| Q92702627 | IGF2/IGF1R Signaling as a Therapeutic Target in MYB-Positive Adenoid Cystic Carcinomas and Other Fusion Gene-Driven Tumors |
| Q37328268 | Identification of Insulin-Like Growth Factor-I Receptor (IGF-IR) Gene Promoter-Binding Proteins in Estrogen Receptor (ER)-Positive and ER-Depleted Breast Cancer Cells. |
| Q34223145 | Identification of a DNA-binding site and transcriptional target for the EWS-WT1(+KTS) oncoprotein |
| Q44259989 | Induction of BAIAP3 by the EWS-WT1 chimeric fusion implicates regulated exocytosis in tumorigenesis. |
| Q38290072 | Induction of the interleukin-2/15 receptor beta-chain by the EWS-WT1 translocation product. |
| Q39108056 | Lost miRNA surveillance of Notch, IGFR pathway--road to sarcomagenesis |
| Q36743270 | Modification of EWS/WT1 functional properties by phosphorylation |
| Q30168994 | Modulation of EWS/WT1 activity by the v-Src protein tyrosine kinase |
| Q58776408 | Molecular Signatures of the Insulin-like Growth Factor 1-mediated Epithelial-Mesenchymal Transition in Breast, Lung and Gastric Cancers |
| Q33747747 | Molecular strategies for detecting chromosomal translocations in soft tissue tumors (review). |
| Q35508728 | Myeloablative chemotherapy with autologous stem cell transplant for desmoplastic small round cell tumor |
| Q49887886 | Oncogenic fusion proteins adopt the insulin-like growth factor signaling pathway |
| Q34661253 | Overlapping RNA and DNA binding domains of the wt1 tumor suppressor gene product |
| Q36163571 | Role of insulin-like growth factor 1 receptor signalling in cancer |
| Q30395770 | Small Is Beautiful: Insulin-Like Growth Factors and Their Role in Growth, Development, and Cancer |
| Q28257266 | Stimulation of hTAFII68 (NTD)-mediated transactivation by v-Src |
| Q41727239 | Structure and function of the insulin-like growth factor I receptor |
| Q21285014 | Targeted therapies in sarcomas: challenging the challenge |
| Q37975246 | Targeting the insulin-like growth factor 1 receptor (IGF1R) signaling pathway for cancer therapy |
| Q48684446 | The IGF-I receptor in cell growth, transformation and apoptosis |
| Q35036870 | The IGFI receptor gene: a molecular target for disrupted transcription factors |
| Q28142781 | The N-terminal domain of human TAFII68 displays transactivation and oncogenic properties |
| Q40542365 | The oncogenic fusion protein EWS/NOR-1 induces transformation of CFK2 chondrogenic cells |
| Q34001125 | The predominant WT1 isoform (+KTS) encodes a DNA-binding protein targeting the planar cell polarity gene Scribble in renal podocytes. |
| Q38612221 | The role of insulin-like growth factor system in soft tissue sarcomas: from physiopathology to targeted therapeutic approaches |
| Q37931268 | Therapeutic pipeline for soft-tissue sarcoma |
| Q40653110 | Transcriptional regulation of IGF-I receptor gene expression by novel isoforms of the EWS-WT1 fusion protein |
| Q97681227 | Transcriptome analysis of desmoplastic small round cell tumors identifies actionable therapeutic targets: a report from the Children's Oncology Group |
| Q34990678 | Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors. desmoplastic small round-cell tumors |
| Q37973027 | Updates on the multimodality management of desmoplastic small round cell tumor |
| Q28191433 | WT1 proteins: functions in growth and differentiation |